menu

Call to Action: Elevating CKD-aP Care

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Call to Action: Elevating CKD-aP Care

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Related
Comments
  • Overview

    Explore the latest breakthroughs in CKD-associated pruritus care by delving into the utilization of difelikefalin, a peripheral kappa-opioid receptor (KOR) agonist with proven sustained efficacy. Uncover the significant relief it can offer in alleviating the burden of itch in patients with moderate to severe CKD-aP and the profound impact you can make on enhancing the overall quality of life for your patients grappling with this bothersome condition.

  • Provider(s)/Educational Partner(s)


    Our ultimate goal is to improve the care being delivered to patients, and our high-quality, evidence-based CME initiatives reflect our dedication to the creation and execution of excellence and are the product of shared research, knowledge, and clinical practice skills across the healthcare continuum. 

  • Commercial Support

    This activity is supported by an independent educational grant from CSL Vifor.

Facebook Comments

Recommended
Details
Presenters
Related
Comments
  • Overview

    Explore the latest breakthroughs in CKD-associated pruritus care by delving into the utilization of difelikefalin, a peripheral kappa-opioid receptor (KOR) agonist with proven sustained efficacy. Uncover the significant relief it can offer in alleviating the burden of itch in patients with moderate to severe CKD-aP and the profound impact you can make on enhancing the overall quality of life for your patients grappling with this bothersome condition.

  • Provider(s)/Educational Partner(s)


    Our ultimate goal is to improve the care being delivered to patients, and our high-quality, evidence-based CME initiatives reflect our dedication to the creation and execution of excellence and are the product of shared research, knowledge, and clinical practice skills across the healthcare continuum. 

  • Commercial Support

    This activity is supported by an independent educational grant from CSL Vifor.

Facebook Comments

Schedule14 Apr 2024